Local media reports in the UK suggest that the BioIndustry Association (BIA) is touting for government funding via the National Health Service, in exchange for a share in any profits made by some of its member firms.
A report in the Independent on Sunday newspaper claims that the BIA "expects to submit its proposal in the autumn." A spokesperson for the BIA told the Marketletter that the report was "premature" and "out of context."
However, the BIA is investigating a number of funding options for the industry in the future, she added.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Sign up to receive email updates
Join industry leaders for a daily roundup of biotech & pharma news
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze